[{"data":1,"prerenderedAt":63},["ShallowReactive",2],{"q-nurse-106-2-medical-surgical-034":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":33,"lastmod":62},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-106-2-內外科護理學-034","nurse-106-2-medical-surgical-034",106,2,34,"有關乳癌病人荷爾蒙治療之敘述，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"治療副作用有倦怠、皮膚癢、噁心嘔吐等","停經後婦女比停經前婦女的治療效果好","Tamoxifen 是轉移性乳癌第一線用藥，一般療程為 5 年","體內動情素受體和黃體素受體含量越低，治療反應越好","D",null,[],"本題考點是乳癌荷爾蒙治療的療效預測與用藥。依機轉,荷爾蒙治療針對受體陽性腫瘤,體內動情素受體(ER)與黃體素受體(PR)含量『越高』,治療反應越好,故(D)『含量越低反應越好』錯誤。(A)Tamoxifen等常見副作用有倦怠、皮膚癢、噁心嘔吐,正確。(B)停經後婦女對荷爾蒙治療反應通常優於停經前,正確。(C)Tamoxifen為轉移性乳癌第一線用藥、療程約5年,正確。故受體含量與療效呈正相關為判題關鍵。","荷爾蒙治療對象為ER或PR陽性者。停經前用Tamoxifen(選擇性動情素受體調節劑,SERM);停經後可用芳香環酶抑制劑(aromatase inhibitor)。Tamoxifen需注意增加子宮內膜癌與血栓風險。受體陽性代表腫瘤生長依賴荷爾蒙,阻斷後反應佳;三陰性乳癌(ER、PR、HER2皆陰)則對荷爾蒙治療無效。",[24,27,29,31],{"term":25,"count":26},"乳癌荷爾蒙治療",1,{"term":28,"count":26},"動情素受體",{"term":30,"count":26},"Tamoxifen",{"term":32,"count":26},"停經狀態",[34,38,43,47,52,57],{"webId":35,"stem":36,"number":37,"year":9,"session":10},"nurse-106-2-medical-surgical-035","章小姐在癌症治療過程中，向護理師反應「我快要死了，再也看不到我女兒了」，以庫伯勒-羅斯癌症病人的心理反應，是屬於下列那個階段？",35,{"webId":39,"stem":40,"number":41,"year":42,"session":26},"nurse-107-1-medical-surgical-051","有關急性呼吸窘迫症候群（ARDS）的診斷標準，下列何者正確？",51,107,{"webId":44,"stem":45,"number":46,"year":42,"session":10},"nurse-107-2-medical-surgical-065","有關接受前列腺切除術病人之護理措施與指導，下列何者錯誤？",65,{"webId":48,"stem":49,"number":50,"year":51,"session":26},"nurse-109-1-medical-surgical-023","有關扁桃腺炎病人接受扁桃腺切除術之敘述，下列何者錯誤？",23,109,{"webId":53,"stem":54,"number":55,"year":56,"session":26},"nurse-110-1-medical-surgical-067","有關良性前列腺肥大的合併症，下列何者錯誤？",67,110,{"webId":58,"stem":59,"number":60,"year":61,"session":10},"nurse-111-2-medical-surgical-021","有關骨科手術合併症的敘述，下列何者錯誤？",21,111,"2026-09-04",1788510698557]